Soonklang相关文献与解析，生知库 | 链接生命科学的每一步

The impact of alternative care pathways adopted during the COVID-19 pandemic on the management of non-communicable diseases at a tertiary care hospital in Thailand

新冠疫情期间采用的替代性诊疗路径对泰国一家三级医院非传染性疾病管理的影响

期刊:Journal of Pharmaceutical Policy and Practice

影响因子:2.5

doi:10.1080/20523211.2025.2544644

Chongpornchai, Jongkonnee; Phodha, Tuangrat; Wongphan, Thanawat; Soonklang, Kamonwan; Coyte, Peter C

Comparison of real-time instrument use and absorbent tube method for measuring formaldehyde in working environments: A health risk assessment for gross anatomy staff

实时仪器法与吸收管法测定工作环境中甲醛含量的比较：对人体解剖工作人员的健康风险评估

期刊:Toxicology Reports

影响因子:

doi:10.1016/j.toxrep.2025.101913

Soonklang, Phanpina; Ketsakorn, Arroon; Homkham, Nontiya; Chaikittiporn, Chalermchai; Norkaew, Saowanee

发表日期：2025

文献求助收藏

Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in Thailand

新冠疫情之后：泰国高血压和糖尿病管理远程医疗服务的预算影响分析

期刊:

影响因子:

doi:10.2147/CEOR.S538395

Chongpornchai, Jongkonnee; Phodha, Tuangrat; Wongphan, Thanawat; Soonklang, Kamonwan; Coyte, Peter C

Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev)

评估法匹拉韦对家庭内 SARS-CoV-2 传播的影响：一项多中心研究的启示 (FaviPrev)

期刊:Journal of Virus Eradication

影响因子:2

doi:10.1016/j.jve.2024.100576

Siripongboonsitti, Taweegrit; Muadchimkaew, Marisa; Tawinprai, Kriangkrai; Issaranon, Ornisa; Meepholkij, Wichuda; Arttawejkul, Pureepat; Vararungzarit, Apiradee; Dhissayakamol, Onwalee; Preeyachit, Wilaiporn; Soonklang, Kamonwan; Mahanonda, Nithi

SARS-CoV-2

发表日期：2024

文献求助收藏

Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab)

新冠肺炎康复者血浆联合口服 RNA 依赖性 RNA 聚合酶抑制剂治疗与中和单克隆抗体治疗在新冠肺炎门诊患者中的疗效比较：一项多中心、非劣效性、开放标签随机对照试验 (PlasMab)

期刊:Microbiology Spectrum

影响因子:3.8

doi:10.1128/spectrum.03257-23

Siripongboonsitti, Taweegrit; Nontawong, Nuttakant; Tawinprai, Kriangkrai; Suptawiwat, Ornpreya; Soonklang, Kamonwan; Poovorawan, Yong; Mahanonda, Nithi

Observational study investigating the relationship between maxillomandibular characteristics and temporomandibular disc conditions in female patients with a skeletal class III pattern

一项观察性研究，旨在探讨骨性III类错颌女性患者的颌骨特征与颞下颌关节盘状况之间的关系。

期刊:Journal of Orthodontic Science

影响因子:

doi:10.4103/jos.jos_28_23

Suntornchatchaweach, Supakorn; Hoshi, Kenji; Okamura, Kazutoshi; Yoshiura, Kazunori; Soonklang, Kamonwan; Takahashi, Ichiro

发表日期：2023

文献求助收藏

The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study

高滴度中和抗体康复者血浆疗法对早期重症COVID-19患者的临床疗效：一项病例对照研究

期刊:Annals of Clinical Microbiology and Antimicrobials

影响因子:3.6

doi:10.1186/s12941-022-00542-2

Nontawong, Nuttakant; Siripongboonsitti, Taweegrit; Tawinprai, Kriangkrai; Boonpratoom, Mana; Krailassiri, Nawin; Boonkhum, Chayaporn; Soonklang, Kamonwan; Poovorawan, Yong; Mahanonda, Nithi

发表日期：2022

文献求助收藏

Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population

泰国人群单剂接种 ChAdOx1 (AZD1222) COVID-19 疫苗后免疫原性的持久性、免疫反应的促成因素和反应原性

期刊:Human Vaccines & Immunotherapeutics

影响因子:3.5

doi:10.1080/21645515.2022.2035573

Tawinprai, Kriangkrai; Siripongboonsitti, Taweegrit; Porntharukchareon, Thachanun; Dechates, Bothamai; Monprach, Harnphadungkit; Sornsamdang, Gaidganok; Wittayasak, Kasiruck; Soonklang, Kamonwan; Mahanonda, Nithi

免疫/内分泌

发表日期：2022

文献求助收藏

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

使用CoronaVac和ChAdox1 nCov-19 (AZD1222)疫苗进行异源初免-加强免疫后的免疫原性和反应原性

期刊:Human Vaccines & Immunotherapeutics

影响因子:3.5

doi:10.1080/21645515.2022.2052525

Cohen, Guy; Jungsomsri, Pawornrath; Sangwongwanich, Jirath; Tawinprai, Kriangkrai; Siripongboonsitti, Taweegrit; Porntharukchareon, Thachanun; Wittayasak, Kasiruck; Thonwirak, Nawarat; Soonklang, Kamonwan; Sornsamdang, Gaidganok; Auewarakul, Chirayu; Mahanonda, Nithi

免疫/内分泌

发表日期：2022

文献求助收藏

Correlation of microbilirubin with total serum bilirubin and transcutaneous bilirubin

微量胆红素与血清总胆红素和经皮胆红素的相关性

The impact of alternative care pathways adopted during the COVID-19 pandemic on the management of non-communicable diseases at a tertiary care hospital in Thailand

新冠疫情期间采用的替代性诊疗路径对泰国一家三级医院非传染性疾病管理的影响

Comparison of real-time instrument use and absorbent tube method for measuring formaldehyde in working environments: A health risk assessment for gross anatomy staff

实时仪器法与吸收管法测定工作环境中甲醛含量的比较：对人体解剖工作人员的健康风险评估

Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in Thailand

新冠疫情之后：泰国高血压和糖尿病管理远程医疗服务的预算影响分析

Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev)

评估法匹拉韦对家庭内 SARS-CoV-2 传播的影响：一项多中心研究的启示 (FaviPrev)

Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab)

新冠肺炎康复者血浆联合口服 RNA 依赖性 RNA 聚合酶抑制剂治疗与中和单克隆抗体治疗在新冠肺炎门诊患者中的疗效比较：一项多中心、非劣效性、开放标签随机对照试验 (PlasMab)

Observational study investigating the relationship between maxillomandibular characteristics and temporomandibular disc conditions in female patients with a skeletal class III pattern

一项观察性研究，旨在探讨骨性III类错颌女性患者的颌骨特征与颞下颌关节盘状况之间的关系。

The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study

高滴度中和抗体康复者血浆疗法对早期重症COVID-19患者的临床疗效：一项病例对照研究

Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population

泰国人群单剂接种 ChAdOx1 (AZD1222) COVID-19 疫苗后免疫原性的持久性、免疫反应的促成因素和反应原性

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

使用CoronaVac和ChAdox1 nCov-19 (AZD1222)疫苗进行异源初免-加强免疫后的免疫原性和反应原性